ClinicalTrials.Veeva

Menu

Light Stimulation to Improve Visual Function After Optic Neuritis in Persons with Multiple Sclerosis (ONSTIM)

T

Technical University of Munich

Status

Enrolling

Conditions

Multiple Sclerosis, Relapsing-Remitting
Optic Neuritis

Treatments

Device: Sham light stimulation
Device: Light stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT06389968
2023-491-S-KH

Details and patient eligibility

About

The aim of this monocentric randomized controlled intervention study is to improve visual function in persons with multiple sclerosis following optic neuritis (neuritis nervi optici) by means of a light stimulation.

In the treatment arm, two 80-second light stimulations are to be administered daily for 12 days in 25 persons with multiple sclerosis following recent optic neuritis (1-3 months). For the standardized application of light stimulation in the sense of standardized training, the light stimulation is to be carried out by watching a generated flicker video on a mobile phone. In a sham-intervened control group (sample size 25), the spontaneous course after optic neuritis will be recorded in parallel. Intensive neuronal stimulation of the visual pathway will be used to stimulate regenerative processes, which will be recorded by means of changes in high-contrast visual acuity (primary endpoint). Secondary endpoints are changes in a colored-contrast test, in 2.5% low contrast visual acuity, the peak conduction latency of visual evoked potentials, and retinal layer thicknesses and vessel densities measured in optical coherence tomography and optical coherence tomorgraphic angiography. These physiological parameters should help to understand the underlying processes of a potentially altered visual performance.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Relapsing remitting multiple sclerosis or clinically isolated syndrome or no indication of chronic inflammatory central nervous system disease
  • Age 18-60 years
  • Optic neuritis within 1-3 months

Exclusion criteria

  • Epilepsy
  • Light-triggered migraine
  • Insufficient vision correction
  • Retinal disease (glaucoma, macular edema, macula degeneration, ...)

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

50 participants in 2 patient groups

Light stimulation
Experimental group
Description:
Experimental light stimulation (3 colors at 20 Hertz each for 80 seconds twice a day).
Treatment:
Device: Light stimulation
Sham light stimulation
Sham Comparator group
Description:
Sham light stimulation (white screen for 80 seconds twice a day).
Treatment:
Device: Sham light stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Philipp Gulde Gulde, Dr. phil.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems